Defence Therapeutics Stock Price on December 10, 2024
| DTCFF Stock | USD 0.39 0.00 0.00% |
If you're considering investing in Defence OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Defence Therapeutics stands at 0.39, as last reported on the 8th of January, with the highest price reaching 0.39 and the lowest price hitting 0.39 during the day. Defence Therapeutics appears to be out of control, given 3 months investment horizon. Defence Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0336, which denotes the company had a 0.0336% return per unit of risk over the last 3 months. We have found eighteen technical indicators for Defence Therapeutics, which you can use to evaluate the volatility of the firm. Please utilize Defence Therapeutics' Mean Deviation of 2.4, standard deviation of 9.97, and Variance of 99.3 to check if our risk estimates are consistent with your expectations.
Defence OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Defence |
Sharpe Ratio = 0.0336
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | DTCFF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 10.2 actual daily | 90 90% of assets are less volatile |
Expected Return
| 0.34 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Defence Therapeutics is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Defence Therapeutics by adding it to a well-diversified portfolio.
Related Headline
Regeneron Pharmaceuticals Headline on 10th of December 2024
Immune-Onc Therapeutics Presents Updated Data from Phase 1b ... by finance.yahoo.com
PALO ALTO, Calif., December 10, 2024--Immune-Onc Therapeutics, Inc. , a private clinical-stage biopharmaceutical company advancing novel therapies in immunology and oncology by targeting myeloid cell inhibitory receptors, today presented updated data from its Phase 1b expansion cohort evaluating IO-202, a first-in-class anti-LILRB4 antibody, in combination with azacitidine in patients with chronic myelomonocytic leukemia . These new findings were highlighted in an oral
Defence Therapeutics Valuation on December 10, 2024
It is possible to determine the worth of Defence Therapeutics on a given historical date. On December 10, 2024 Defence was worth 0.41 at the beginning of the trading date compared to the closed value of 0.41. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Defence Therapeutics otc stock. Still, in general, we apply an absolute valuation method to find Defence Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Defence Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Defence Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.41 | 0.41 | 0.41 | 0.41 | 1.00 | |
12/10/2024 | 0.41 | 0.41 | 0.41 | 0.41 | 1.00 |
| 0.41 | 0.41 | 0.41 | 0.41 | 1.00 |
| Backtest Defence Therapeutics | | | Defence Therapeutics History | | | Defence Therapeutics Valuation | Previous | Next |
Defence Therapeutics Trading Date Momentum on December 10, 2024
| On December 11 2024 Defence Therapeutics was traded for 0.41 at the closing time. The highest daily price throughout the period was 0.41 and the lowest price was 0.41 . There was no trading activity during the period 1.0. Lack of trading volume on 12/11/2024 did not affect price variability. The overall trading delta to current closing price is 34.15% . |
Defence Therapeutics Fundamentals Correlations and Trends
By evaluating Defence Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Defence Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Defence financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Defence Therapeutics OTC Stock history
Defence Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Defence is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Defence Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Defence Therapeutics stock prices may prove useful in developing a viable investing in Defence Therapeutics
Defence Therapeutics Inc., a biotechnology company, engages in the research and development of biologicalbiosimilar therapeutic drugs for cancer and infectious diseases. Defence Therapeutics Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada. Defence Therapeutics is traded on OTC Exchange in the United States.
Defence Therapeutics OTC Stock Technical Analysis
Defence Therapeutics technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Price Boundaries
Defence Therapeutics Period Price Range
Low | January 8, 2025
| High |
0.00 | 0.00 |
Defence Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQB Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Defence Therapeutics January 8, 2025 Market Strength
Market strength indicators help investors to evaluate how Defence Therapeutics otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Defence Therapeutics shares will generate the highest return on investment. By undertsting and applying Defence Therapeutics otc stock market strength indicators, traders can identify Defence Therapeutics entry and exit signals to maximize returns
Defence Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Defence Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Defence OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Defence to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0357 | |||
| Jensen Alpha | 0.3099 | |||
| Total Risk Alpha | 0.0942 | |||
| Treynor Ratio | 0.831 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Defence OTC Stock analysis
When running Defence Therapeutics' price analysis, check to measure Defence Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Defence Therapeutics is operating at the current time. Most of Defence Therapeutics' value examination focuses on studying past and present price action to predict the probability of Defence Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Defence Therapeutics' price. Additionally, you may evaluate how the addition of Defence Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |